On March 18-19, Caszyme’s CEO, Monika Paule, and Business Development Director, Donatas Staniulis, will be in London for Europe’s largest Cell & Gene Therapy event – Advanced Therapies Congress 2025.
We’re excited to connect and discuss how CRISPR drives innovation and how Caszyme can contribute to developing next-generation therapies.
Let’s meet:
– Come swing by our Booth #56;
– Explore our Poster “Unlocking the Transformative Power of CRISPR Gene Editing in Advanced Therapies”;
– Reach out to set up a meeting!